home All News open_in_new Full Article

Thousands of NHS patients ‘to be denied breakthrough Alzheimer’s drugs’

Drugs that slow progression of Alzheimer’s don’t provide enough benefit to justify substantial cost for NHS, regulator has said


today 3 w. ago attach_file Events

attach_file Economics
attach_file Science
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Events
attach_file Events


ID: 1104543398
Add Watch Country

arrow_drop_down